Rein Therapeutics Inc. (RNTX)
Market Open
11 Sep, 14:53
NASDAQ (CM) NASDAQ (CM) Primary $
0. 79
+0.01
+1.319%
$
24.86M Market Cap
- P/E Ratio
- Div Yield
34,878 Volume
- Eps
$ 0.78
Previous Close Want to track RNTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rein Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JRP Jay R. Petschek Corsair Capital Management LP | 80,000 | $83,200 | $64,480 | -$18,720 | -22.5% |
| YA Yinka Akinsola Blue Trust Inc. | 20 | $35.4 | $15.51 | -$19.89 | -56.19% |
 Richard Slavik Newbridge Financial Services Group Inc. | 97 | $126.1 | $75.2 | -$50.9 | -40.36% |
 Tyler Glazier New Millennium Group LLC | 2,038 | $2,364.08 | $1,502.01 | -$862.07 | -36.47% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 1 | $1.33 | $0.78 | -$0.55 | -41.35% |
